| NO. |
Product name |
Method |
Clinical Significance |
| 1 |
Cystatin C (CYS-C), urine sample |
Latex-enhanced Immunoturbidimetry |
Indicator of glomerular filtration |
| 2 |
β2- Microglobulin (β2-MG), urine sample |
Latex-enhanced Immunoturbidimetry |
For evaluation of renal function |
| 3 |
Neutrophil Gelatinase-Associated Lipid Transporting Protein |
Latex-enhanced Immunoturbidimetry |
Marker for diagnosis of early renal injury |
| 4 |
Urine Retinol Binding Protein (U-RBP), urine sample |
Latex-enhanced Immunoturbidimetry |
As an early diagnostic indicator of renal tubular injury |
| 5 |
α1-Microglobulin (α1-MG), urine sample |
Enzyme Kinetic |
A specific indicator for early diagnosis of renal impairment |
| 6 |
N-acetyl-β-D aminoglucosidase (NAG), urine sample |
Enzyme Kinetic |
Sensitive indicator for early kidney injury and diabetic microangiopathy |
| 7 |
Creatinine (CREA), urine sample |
Sarcosine Oxidase |
For comprehensive assessment of renal function |
| 8 |
Uric acid (UA), urine sample |
Uricase-coupled Endpoint |
For evaluation of renal function and diagnosis of gout and urinary stones |
| 9 |
Urea (UREA), urine sample |
Urease |
Used in the assessment of renal function |
| 10 |
Cerebrospinal Fluid and Urine Total Protein (CSF), Urine Sample |
Catetriol Red Chromogenic |
For evaluation of renal function |
| 11 |
Urine microalbumin (mALB), urine sample |
Immunoturbidimetry |
For evaluation of renal injury |
| 12 |
Urinary immunoglobulin G (U-IgG) |
Immunoturbidimetry |
To assess the degree of glomerular filtration membrane damage and to observe the effect of treatment |
| 13 |
Total bilirubin (TBil) |
Vanadate Oxidation |
For the diagnosis of biliary tract obstruction, hepatitis and cirrhosis of the liver |
| 14 |
Direct bilirubin (DBil) |
Vanadate Oxidation |
For diagnostic indicators of viral hepatitis and obstructive jaundice |
| 15 |
α- Amylase (AMY) |
CNP-G3 Substrate Kinetics |
For the diagnosis of acute pancreatitis and other acute abdominal diseases |
| 16 |
Transferrin (TRF) |
Immunoturbidimetry |
For reflecting the damage to the glomerular charge barrier |
| 17 |
Urinary Iodine (U-IOD) |
Colorimetric Kinetics |
For monitoring of thyroid disorders |
| 18 |
Glucose (GLU-HK) |
Hexokinase |
For the evaluation of diabetes mellitus and glomerular filtration function |
| 19 |
κ Light chain (κ-LC/KAP) |
Immunoturbidimetry |
For use in the diagnosis of autoimmune diseases |
| 20 |
λ Light chain (λ-LC / LAM) |
Immunoturbidimetry |
For the diagnosis of autoimmune diseases |
| 21 |
Urine Total Protein (U-TP) |
Immunoturbidimetry |
For the treatment, evaluation and prognosis of chronic kidney disease |
| 22 |
α2- Macroglobulin (α2-MG) |
Immunoturbidimetry |
For differential diagnosis of glomerular and non-glomerular hematuria |
| 23 |
Leucine aminopeptidase (LAP) |
Kinetic Rate |
For the auxiliary diagnosis of tumor recurrence and renal diseases |
| 24 |
Pancreatic amylase (P-AMY) |
Selective Inhibition |
For rapid diagnosis of acute pancreatitis |
